'Where we are today in biology AI is similar to GPT in 2020': An interview with the CEO of Africa's biggest AI startup | TechCrunch
Briefly

Since the acquisition by BioNTech, Instadeep has advanced its AI capabilities significantly, aligning with BioNTech's focus on therapeutics while continuing to serve other clients.
Instadeep and BioNTech's strategic alignment allows for leveraging AI in biopharmaceutical innovations, enhancing efforts in developing therapeutics and vaccines for infectious diseases.
Read at TechCrunch
[
|
]